Australia blocks Cosette Pharmaceuticals bid to buy Mayne Pharma

Core Viewpoint - Australia has blocked a A$672 million ($433 million) buyout offer for Mayne Pharma from U.S. drugmaker Cosette Pharmaceuticals, citing national interest [1] Group 1: Transaction Details - The blocked buyout offer was valued at A$672 million ($433 million) [1] Group 2: Regulatory Context - The Australian government intervened in the transaction, indicating a focus on national interest considerations in foreign acquisitions [1]